Results 21 to 30 of about 6,465,161 (268)

Progression-free survival rate.

, 2019
Progression-free survival rate.
Sonia Tejada (4023731), Luis Ramos (550823), José Javier Aristu (6808193), Miguel Ángel Idoate (6808184), Paola Anna Jablonska (6808178), Ricardo Diez-Valle (198834), Marta Moreno-Jiménez (6808181), Maria Reyes Garcia de Eulate (6808187), Pablo Domínguez (4023716), Jaime Gállego Pérez-Larraya (842444), Leire Arbea (6686129), Javier Arbizu (6808190)   +11 more
core   +1 more source

Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice

Acta Oncologica
Background: The modern-day therapeutic landscape for follicular lymphoma (FL) includes a number of highly effective therapies. Patients and methods: We set out to determine progression-free survival (PFS) after front line, second line, and third line of
Aino Rajamaki, Marc Sorigue, Roosa E.I. Prusila, Milla E.L. Kuusisto, Hanne Kuitunen, Esa Jantunen, Santiago Mercadal, Taina Turpeenniemi-Hujanen, Juan-Manuel Sancho, Kaisa Sunela, Outi Kuittinen   +10 more
doaj   +1 more source

Optimal duration of a first-line palliative chemotherapy in disseminated colorectal cancer – a review of the literature from a developing country perspective

Contemporary Oncology, 2016
We still do not know whether the presently used protocol of the first-line palliative treatment of disseminated colorectal cancer (FOLFOX/FOLFIRI protocol) allows maximization of therapeutic response and minimization of side effects.
Wojciech Rogowski, Violetta Sulżyc-Bielicka   +1 more
doaj   +1 more source

Progression-free survival and survival estimates for TDM vs. NTDM.

, 2019
Progression-free survival (PFS, blue) and survival (orange) estimates. Estimates from TDM on solid lines; estimates from NTDM on dotted lines. Note: Progression-Free Survival: likelihood of staying in CP with either imatinib or second-generation TKI ...
Philip S. Bernard (8173509), Srinivas Tantravahi (8173512), Gwendolyn A. McMillin (8173506), Robert L. Schmidt (8173518), Kibum Kim (1420720), Brandon S. Walker (8173515)   +5 more
core   +1 more source

Progression-free survival (PFS) and overall survival (OS).

, 2016
Progression-free survival (PFS) and overall survival (OS).
Udi Sadeh Gonik (3157254), Baruch Brenner (432625), Efraim Idelevich (3157263), Amir Abramovich (3157257), Gal Medalia (3157266), Ofer Purim (432618), Limor Amit (275734), Michal Sarfaty (3157260), Yulia Kundel (432617), Aaron Sulkes (432624), Noa Gordon (3157251)   +10 more
core   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

Long Term Clinical Outcomes of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Single Center Study [PDF]

The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Objectives Few studies have reported long-term follow-up after treatment of gastric mucosaassociated lymphoid tissue (MALT) lymphoma. In this single-center study, we investigated longterm treatment outcomes in patients diagnosed with gastric MALT ...
Seong Hyun Koh, Seung Hyun Yeo, Moo In Park, Kyoungwon Jung, Sung Eun Kim, Won Moon, Seun Ja Park   +6 more
doaj   +1 more source

Progression-free survival of the VS combination

, 2016
Progression-free survival of the VS ...
Oriana Nanni (16186), Helen Charamis (3592043), Khashayar Esfahani (3592046), Emanuela Scarpi (382324), Lawrence C. Panasci (3592037), Cristiano Ferrario (3592034), Ivan Strepponi (2452123), Wilson H. Miller Jr (504574), Adrian Langleben (3592040)   +8 more
core   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger   +10 more
wiley   +1 more source

Progression-free survival for STS: multivariate analysis.

, 2017
Progression-free survival for STS: multivariate analysis.
Gualter Vaz (3715726), Olivier Collard (3715720), Dominique Ranchere-Vince (3715738), Pierre Meeus (3451424), Anne-Valérie Decouvelaere (346741), Eric De Laroche (3715729), Claire Cropet (3715732), Philippe Cassier (3451427), François-Noel Gilly (3715735), Pierre Etienne Heudel (3715741), Fadila Farsi (3715723), Isabelle Ray-Coquard (346757), Pierre Biron (3715714), Philippe Thiesse (804468), Jean-Yves Blay (72864), Olfa Derbel (3715717), Dominic Cellier (346755)   +16 more
core   +1 more source